Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% - Tale of the Tape

Alcobra Ltd. ADHD saw a big move last session, as the company's shares fell by nearly 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for ADHD, as the stock is now down almost 11% in the past one-month time frame.

The biopharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

ADHD currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the Medical Drugs industry may consider better-ranked stocks like Ariad Pharmaceuticals Inc. ARIA, Grifols, S.A. GRFS and IGI, Laboratories, Inc. IG. All these stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ALCOBRA LTD ADHD: Get Free Report
 
ARIAD PHARMA ARIA: Free Stock Analysis Report
 
GRIFOLS SA-ADR GRFS: Free Stock Analysis Report
 
IGI LABORATORYS IG: Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!